FDA Approves Lipfendra, the First Once-Daily Oral PCSK9 Inhibitor for Lowering LDL Cholesterol
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily oral medication designed to help adults lower...
Cholesterol
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), a once-daily oral medication designed to help adults lower...
